Challenges in Mergers and Acquisition…

Answer preview

One of the most controversial engagements in the commercial space was the failed merger between Pfizer and Allergan (Cyran, 2016). The union would have been worth $152 billion, a colossal amount that would have changed the fortunes of both companies. Experts in matters appertaining to mergers and acquisition called the deal overpriced and too risky considering the massive resources involved. The deal would have seen the two entities reduce their tax obligations as they could have shifted their base to a country with a more favorable regime. While all the parties were to blame for the deal’s ultimate collapse, Pfizer’s CEO Ian C. Read attracted the most scathing criticism because of timewasting that gave the treasury sufficient time to halt the agreement (Cyran, 2016).

[485 Words]

Challenges in Mergers and Acquisition